Dingxin Capital
32
4M
29
3.20
2
0.06
1
- Stages of investment
- Areas of investment
Summary
Dingxin Capital is the famous VC, which was founded in 2014. The venture was found in Asia in China. The main department of described VC is located in the Shenzhen.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Etailor, Koning Among the most successful fund investment fields, there are Health Care, E-Commerce.
The usual cause for the fund is to invest in rounds with 2 partakers. Despite the Dingxin Capital, startups are often financed by Sansar Capital. The meaningful sponsors for the fund in investment in the same round are Weipinhui, Oriza Seed Capital (Oriza Yuandian), Guangdong Culture Venture Factory.
The top activity for fund was in 2019. The common things for fund are deals in the range of 5 - 10 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
Investments analytics
Analytics
- Total investments
- 32
- Lead investments
- 2
- Exits
- 1
- Rounds per year
- 3.20
- Follow on index
- 0.06
- Investments by industry
- Medical (6)
- Biotechnology (5)
- Manufacturing (5)
- Medical Device (4)
- Semiconductor (4) Show 42 more
- Investments by region
-
- China (31)
- Peak activity year
- 2017
- Number of Decacorns
- 1
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Avg. valuation at time of investment
- 34M
- Group Appearance index
- 0.59
- Avg. company exit year
- 5
- Avg. multiplicator
- 0.45
- Strategy success index
- 0.10
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Jifu Medical | 01 Jan 2017 | Health Diagnostics, Medical Device, Medical | Early Stage Venture | Shenzhen, Guangdong, China | |
| Zhihe Biotechnology | 20 May 2024 | Biotechnology, Manufacturing, Chemical | Seed | Nanjing, Jiangsu, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.